Dr. rer. nat. Frauke Degenhardt is a Data Scientist at Indivumed Group since August 2022, specializing in therapeutic target discovery and multi-omics analysis in cancer through classical statistical and machine learning techniques. Previously, Dr. Degenhardt served as a Postdoctoral Researcher at the Institute of Clinical Molecular Biology from August 2013 to August 2022, focusing on the statistical analysis of COVID-19 genetics and HLA genetics in various disease contexts. This role involved project coordination for the Severe COVID-19 GWAS consortium and effective communication of results. Dr. Degenhardt's academic background includes a Doctor of Science in Computational Biology from Kiel University and a Master’s degree in Computational Life Science from Universität zu Lübeck, complemented by a Bachelor's degree in Molecular Life Science.
Sign up to view 0 direct reports
Get started